SCHM vs. BOUT
Compare and contrast key facts about Schwab US Mid-Cap ETF (SCHM) and Innovator IBD Breakout Opportunities ETF (BOUT).
SCHM and BOUT are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. SCHM is a passively managed fund by Charles Schwab that tracks the performance of the Dow Jones US Total Stock Market Mid-Cap. It was launched on Jan 13, 2011. BOUT is a passively managed fund by Innovator that tracks the performance of the IBD Breakout Stocks Total Return Index. It was launched on Sep 13, 2018. Both SCHM and BOUT are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
SCHM vs. BOUT - Performance Comparison
Loading graphics...
SCHM vs. BOUT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
SCHM Schwab US Mid-Cap ETF | 3.21% | 10.17% | 11.98% | 16.69% | -17.07% | 19.36% | 15.26% | 27.48% | -17.52% |
BOUT Innovator IBD Breakout Opportunities ETF | 8.23% | -6.77% | 18.82% | 13.27% | -22.60% | 22.69% | 50.56% | 20.59% | -29.80% |
Returns By Period
In the year-to-date period, SCHM achieves a 3.21% return, which is significantly lower than BOUT's 8.23% return.
SCHM
- 1D
- 3.30%
- 1M
- -5.64%
- YTD
- 3.21%
- 6M
- 5.17%
- 1Y
- 19.92%
- 3Y*
- 12.71%
- 5Y*
- 5.81%
- 10Y*
- 10.20%
BOUT
- 1D
- 2.67%
- 1M
- -3.79%
- YTD
- 8.23%
- 6M
- 1.15%
- 1Y
- 8.69%
- 3Y*
- 8.84%
- 5Y*
- 4.03%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
SCHM vs. BOUT - Expense Ratio Comparison
SCHM has a 0.04% expense ratio, which is lower than BOUT's 0.80% expense ratio.
Return for Risk
SCHM vs. BOUT — Risk / Return Rank
SCHM
BOUT
SCHM vs. BOUT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Schwab US Mid-Cap ETF (SCHM) and Innovator IBD Breakout Opportunities ETF (BOUT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SCHM | BOUT | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.95 | 0.40 | +0.55 |
Sortino ratioReturn per unit of downside risk | 1.45 | 0.66 | +0.79 |
Omega ratioGain probability vs. loss probability | 1.20 | 1.09 | +0.11 |
Calmar ratioReturn relative to maximum drawdown | 1.42 | 0.65 | +0.76 |
Martin ratioReturn relative to average drawdown | 6.23 | 1.81 | +4.42 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| SCHM | BOUT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.95 | 0.40 | +0.55 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.30 | 0.21 | +0.09 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.50 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.54 | 0.30 | +0.25 |
Correlation
The correlation between SCHM and BOUT is 0.75, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
SCHM vs. BOUT - Dividend Comparison
SCHM's dividend yield for the trailing twelve months is around 1.41%, more than BOUT's 0.32% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SCHM Schwab US Mid-Cap ETF | 1.41% | 1.46% | 1.43% | 1.50% | 1.67% | 1.13% | 1.31% | 1.48% | 1.56% | 1.27% | 1.51% | 1.54% |
BOUT Innovator IBD Breakout Opportunities ETF | 0.32% | 0.34% | 0.60% | 1.32% | 1.35% | 0.00% | 0.00% | 0.00% | 0.22% | 0.00% | 0.00% | 0.00% |
Drawdowns
SCHM vs. BOUT - Drawdown Comparison
The maximum SCHM drawdown since its inception was -42.43%, which is greater than BOUT's maximum drawdown of -36.75%. Use the drawdown chart below to compare losses from any high point for SCHM and BOUT.
Loading graphics...
Drawdown Indicators
| SCHM | BOUT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -42.43% | -36.75% | -5.68% |
Max Drawdown (1Y)Largest decline over 1 year | -14.16% | -13.73% | -0.43% |
Max Drawdown (5Y)Largest decline over 5 years | -26.46% | -28.28% | +1.82% |
Max Drawdown (10Y)Largest decline over 10 years | -42.43% | — | — |
Current DrawdownCurrent decline from peak | -6.32% | -6.50% | +0.18% |
Average DrawdownAverage peak-to-trough decline | -5.71% | -12.55% | +6.84% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.22% | 4.95% | -1.73% |
Volatility
SCHM vs. BOUT - Volatility Comparison
The current volatility for Schwab US Mid-Cap ETF (SCHM) is 6.87%, while Innovator IBD Breakout Opportunities ETF (BOUT) has a volatility of 8.61%. This indicates that SCHM experiences smaller price fluctuations and is considered to be less risky than BOUT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| SCHM | BOUT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.87% | 8.61% | -1.74% |
Volatility (6M)Calculated over the trailing 6-month period | 12.04% | 17.18% | -5.14% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.13% | 21.74% | -0.61% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 19.52% | 19.54% | -0.02% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 20.41% | 22.96% | -2.55% |